Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach

Detalhes bibliográficos
Autor(a) principal: Trivella, Daniela Barretto Barbosa
Data de Publicação: 2022
Outros Autores: Bruder, Marjorie Christine Paule, Oliveira, Fábio Cesar Bonafé, Porcaro, Renata, Rustiguel, Joane Kathelen, Ribeiro, Leonardo Bergamasco, Felicio, Rafael de, Cunha, Marcos Guilherme da, Nascimento, Andrey Fabricio Ziem, Zeri, Ana Carolina Mattos, Pessa, Lisandra Ravanelli, Mascarello, Alessandra, Guimarães, Cristiano Ruch Werneck, Azevedo, Hatylas, Perfeito, Marcia Luana Gomes, Pagani, Eduardo, Ropke, Cristina Dislich
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Fitos
Texto Completo: https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1346
Resumo: Natural product-based drug discovery is experiencing a new era thanks to the use of cutting-edge technologies and integrated approaches to overcome the difficulties inherent to natural products research. These are highly complex and innovative chemical substances produced by the biota, in particular sessile organisms such as plants and microorganisms, and represent the main source of inspiration for new drugs. The increasing interest in the discovery of medicines based on natural products has pushed the development of new approaches for the identification, characterization and resupply of natural products, which can address some of the challenges related to the development of drugs inspired by molecules from the biodiversity. The aim is to detect and characterize new bioactive natural products, at the same time as reducing costs and time to obtain these molecules. For this, it is necessary to innovate in the processes and technologies applied to the discovery of drugs from natural products. The Molecular Power House (MPH) approach presented in this work makes use of integrated technologies as a way to overcome classic bottlenecks in plant natural products research, which aligned with access to the greatest biodiversity on the planet, positions Brazil in the global scenario of discovering innovative drugs.
id FIOCRUZ-1_3cf131d37bbf29c6453f369351b95cc7
oai_identifier_str oai:ojs.revistafitos.far.fiocruz.br:article/1346
network_acronym_str FIOCRUZ-1
network_name_str Revista Fitos
repository_id_str
spelling Natural Product-based Drug Discovery and the Molecular Power House (MPH) ApproachDescoberta de fármacos a partir de produtos naturais e a abordagem Molecular Power House (MPH)Descoberta e Desenvolvimento de FármacosProdutos NaturaisBiodiversidade BrasileiraMolecular Power HouseCristalografiaMetabolômicaDrug Discovery and DevelopmentNatural ProductsBrazilian BiodiversityPower HouseCrystallographyMetabolomicsNatural product-based drug discovery is experiencing a new era thanks to the use of cutting-edge technologies and integrated approaches to overcome the difficulties inherent to natural products research. These are highly complex and innovative chemical substances produced by the biota, in particular sessile organisms such as plants and microorganisms, and represent the main source of inspiration for new drugs. The increasing interest in the discovery of medicines based on natural products has pushed the development of new approaches for the identification, characterization and resupply of natural products, which can address some of the challenges related to the development of drugs inspired by molecules from the biodiversity. The aim is to detect and characterize new bioactive natural products, at the same time as reducing costs and time to obtain these molecules. For this, it is necessary to innovate in the processes and technologies applied to the discovery of drugs from natural products. The Molecular Power House (MPH) approach presented in this work makes use of integrated technologies as a way to overcome classic bottlenecks in plant natural products research, which aligned with access to the greatest biodiversity on the planet, positions Brazil in the global scenario of discovering innovative drugs.A descoberta de fármacos a partir de produtos naturais vivencia uma nova era graças ao uso de tecnologias de ponta e abordagens integradas para superar as dificuldades inerentes à pesquisa com produtos naturais. Estes são substâncias químicas altamente complexas e inovadoras produzidas pela biota, em especial organismos sésseis como plantas e micro-organismos, e representam a principal fonte de inspiração de novos fármacos. Resultante do reavivado interesse na descoberta de medicamentos à base de produtos naturais, novas abordagens para a identificação, caracterização, e reabastecimento de produtos naturais estão sendo desenvolvidas, que podem endereçar alguns dos desafios relacionados ao desenvolvimento de fármacos inspirados em moléculas da biodiversidade. Almeja-se a capacidade de detecção e caracterização de novos produtos naturais bioativos, concomitantemente à redução dos custos e tempo para obtenção destas moléculas. Para isto, é necessário inovar nos processos e nas tecnologias aplicadas à descoberta de fármacos a partir de produtos naturais. A abordagem Molecular Power House (MPH) apresentada neste trabalho faz uso de tecnologias integradas como uma forma de superar gargalos clássicos da pesquisa com produtos naturais de plantas, alinhada ao acesso à maior biodiversidade do planeta, posicionando o Brasil no cenário mundial de descoberta de fármacos inovadores.Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz2022-03-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmlhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/134610.32712/2446-4775.2022.1346Revista Fitos; Vol. 16 No. Supl. 2 (2022): Bioprospecção; 176-192 Revista Fitos; Vol. 16 Núm. Supl. 2 (2022): Bioprospecção; 176-192 Revista Fitos; v. 16 n. Supl. 2 (2022): Bioprospecção; 176-192 2446-47751808-9569reponame:Revista Fitosinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1346/1001https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1346/1002Copyright (c) 2022 Revista Fitosinfo:eu-repo/semantics/openAccessTrivella, Daniela Barretto BarbosaBruder, Marjorie Christine PauleOliveira, Fábio Cesar Bonafé Porcaro, Renata Rustiguel, Joane KathelenRibeiro, Leonardo Bergamasco Felicio, Rafael deCunha, Marcos Guilherme daNascimento, Andrey Fabricio Ziem Zeri, Ana Carolina Mattos Pessa, Lisandra Ravanelli Mascarello, Alessandra Guimarães, Cristiano Ruch WerneckAzevedo, Hatylas Perfeito, Marcia Luana Gomes Pagani, Eduardo Ropke, Cristina Dislich 2022-03-04T15:38:16Zoai:ojs.revistafitos.far.fiocruz.br:article/1346Revistahttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/PUBhttp://revistafitos.far.fiocruz.br/index.php/revista-fitos/oairevistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br2446-47752446-4775opendoar:2022-03-04T15:38:16Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach
Descoberta de fármacos a partir de produtos naturais e a abordagem Molecular Power House (MPH)
title Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach
spellingShingle Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach
Trivella, Daniela Barretto Barbosa
Descoberta e Desenvolvimento de Fármacos
Produtos Naturais
Biodiversidade Brasileira
Molecular Power House
Cristalografia
Metabolômica
Drug Discovery and Development
Natural Products
Brazilian Biodiversity
Power House
Crystallography
Metabolomics
title_short Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach
title_full Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach
title_fullStr Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach
title_full_unstemmed Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach
title_sort Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach
author Trivella, Daniela Barretto Barbosa
author_facet Trivella, Daniela Barretto Barbosa
Bruder, Marjorie Christine Paule
Oliveira, Fábio Cesar Bonafé
Porcaro, Renata
Rustiguel, Joane Kathelen
Ribeiro, Leonardo Bergamasco
Felicio, Rafael de
Cunha, Marcos Guilherme da
Nascimento, Andrey Fabricio Ziem
Zeri, Ana Carolina Mattos
Pessa, Lisandra Ravanelli
Mascarello, Alessandra
Guimarães, Cristiano Ruch Werneck
Azevedo, Hatylas
Perfeito, Marcia Luana Gomes
Pagani, Eduardo
Ropke, Cristina Dislich
author_role author
author2 Bruder, Marjorie Christine Paule
Oliveira, Fábio Cesar Bonafé
Porcaro, Renata
Rustiguel, Joane Kathelen
Ribeiro, Leonardo Bergamasco
Felicio, Rafael de
Cunha, Marcos Guilherme da
Nascimento, Andrey Fabricio Ziem
Zeri, Ana Carolina Mattos
Pessa, Lisandra Ravanelli
Mascarello, Alessandra
Guimarães, Cristiano Ruch Werneck
Azevedo, Hatylas
Perfeito, Marcia Luana Gomes
Pagani, Eduardo
Ropke, Cristina Dislich
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Trivella, Daniela Barretto Barbosa
Bruder, Marjorie Christine Paule
Oliveira, Fábio Cesar Bonafé
Porcaro, Renata
Rustiguel, Joane Kathelen
Ribeiro, Leonardo Bergamasco
Felicio, Rafael de
Cunha, Marcos Guilherme da
Nascimento, Andrey Fabricio Ziem
Zeri, Ana Carolina Mattos
Pessa, Lisandra Ravanelli
Mascarello, Alessandra
Guimarães, Cristiano Ruch Werneck
Azevedo, Hatylas
Perfeito, Marcia Luana Gomes
Pagani, Eduardo
Ropke, Cristina Dislich
dc.subject.por.fl_str_mv Descoberta e Desenvolvimento de Fármacos
Produtos Naturais
Biodiversidade Brasileira
Molecular Power House
Cristalografia
Metabolômica
Drug Discovery and Development
Natural Products
Brazilian Biodiversity
Power House
Crystallography
Metabolomics
topic Descoberta e Desenvolvimento de Fármacos
Produtos Naturais
Biodiversidade Brasileira
Molecular Power House
Cristalografia
Metabolômica
Drug Discovery and Development
Natural Products
Brazilian Biodiversity
Power House
Crystallography
Metabolomics
description Natural product-based drug discovery is experiencing a new era thanks to the use of cutting-edge technologies and integrated approaches to overcome the difficulties inherent to natural products research. These are highly complex and innovative chemical substances produced by the biota, in particular sessile organisms such as plants and microorganisms, and represent the main source of inspiration for new drugs. The increasing interest in the discovery of medicines based on natural products has pushed the development of new approaches for the identification, characterization and resupply of natural products, which can address some of the challenges related to the development of drugs inspired by molecules from the biodiversity. The aim is to detect and characterize new bioactive natural products, at the same time as reducing costs and time to obtain these molecules. For this, it is necessary to innovate in the processes and technologies applied to the discovery of drugs from natural products. The Molecular Power House (MPH) approach presented in this work makes use of integrated technologies as a way to overcome classic bottlenecks in plant natural products research, which aligned with access to the greatest biodiversity on the planet, positions Brazil in the global scenario of discovering innovative drugs.
publishDate 2022
dc.date.none.fl_str_mv 2022-03-04
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1346
10.32712/2446-4775.2022.1346
url https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1346
identifier_str_mv 10.32712/2446-4775.2022.1346
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1346/1001
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1346/1002
dc.rights.driver.fl_str_mv Copyright (c) 2022 Revista Fitos
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Revista Fitos
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
dc.source.none.fl_str_mv Revista Fitos; Vol. 16 No. Supl. 2 (2022): Bioprospecção; 176-192
Revista Fitos; Vol. 16 Núm. Supl. 2 (2022): Bioprospecção; 176-192
Revista Fitos; v. 16 n. Supl. 2 (2022): Bioprospecção; 176-192
2446-4775
1808-9569
reponame:Revista Fitos
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Revista Fitos
collection Revista Fitos
repository.name.fl_str_mv Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv revistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br
_version_ 1798313476032036864